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Summary 
The induction of tolerance in mice to preparations  of deaggregated human gamma globulin (DHGG) 
results in in vitro antigen-specific unresponsiveness in CD4 + T  cells as well as in both the T 
helper 1 (Thl) and Th2-1ike subpopulations. Whereas both CD45RB  hi and CD45RB  l~ cells from 
lymph nodes of HGG/complete Freund's adjuvant-immunized mice (control) proliferated in vitro 
to HGG, both subpopulations from mice previously tolerized with DHGG failed to respond. 
Furthermore,  CD4 + T  cells from control,  but not from DHGG-injected mice,  secreted high 
levels of interleukin 2 (IL-2) after in vitro stimulation with HGG. Although significant levels 
of IL-4 in supernatants  of control CD4 + cells stimulated with  HGG were detected in some, 
but not all, experiments, significant levels of IL-4 were never detected in supernatants of HGG- 
stimulated tolerant CD4 + cells. The demonstration that serum IgG1 anti-HGG is preferentially 
produced in a few tolerant mice that exhibit a leaky tolerant state suggests that tolerance induction 
may be more dif~cult to induce in  IL-4- than  in IL-2-producing  cells. 
A  solid and long-lasting tolerant state can be induced in 
adult mice by a single injection of deaggregated human 
gamma globulin (DHGG) 1 (for a review see reference  1). Al- 
though tolerance is induced in both T  and B cells,  the dose 
of tolerogen required for B cell tolerance is 2-3 log10 greater 
than that for T  cell tolerance (for a review see reference 1). 
The tolerant state in T  cells is of long duration,  whereas in 
B cells it is of relatively short duration (2). Induction of toler- 
ance in T cells is independent of the thymus and is not con- 
trolled by regulating T cells (3). Although the in vivo induc- 
tion  of tolerance  in  the T  cells can be interfered  with  by 
generators  of IL-1  or IL-1  itself (4,  5),  once induced,  the 
tolerant state cannot be terminated by these reagents. In ad- 
dition to the in vivo induction of tolerance,  tolerance has been 
induced in HGG-specific T  cell clones using either DHGG 
(6, 7) or inappropriate antigen presentation (8-10). Whereas 
tolerance in Thl clones is induced in terms of both prolifera- 
tion and T  cell help,  tolerance in Th2 clones is induced at 
only the T helper level (10, 11). Whether the in vivo induc- 
tion of tolerance occurs in all CD4 + cell populations has re- 
cently been questioned. Data have been reported that imply 
that DHGG induces tolerance in IL-2-producing T cells, but 
induces responsiveness in IL-4-producing cells, resulting in 
IL-4 production  and T  helper  activity (12). 
1Abbreviations  used in  tkis paper: DHGG, deaggregated  human gamma 
globulin; HGG, human gamma globulin. 
In this report, the susceptibility of CD4 § cells and their 
subsets to the induction of tolerance to DHGG was assessed. 
Our results demonstrate that when mice are exposed to HGG 
as a tolerogen before immunization,  such that  the in vitro 
antigen-specific  proliferation  of CD4 +  T  cells  is  totally 
abrogated and serum antibody levels are dramatically reduced, 
antigen-specific proliferation  of both Thl- and Th2-1ike subsets 
is abrogated. Furthermore, a decrease in IL-4 as well as IL-2 
production following antigen stimulation can be demonstrated 
in CD4 + T  cells from tolerant versus control mice.  Thus, 
these results indicate that under appropriate conditions of toler- 
ance induction,  both  Thl-  and Th2-1ike CD4 §  functions 
can be inhibited. 
Materials and Methods 
Animals.  Female CBA/CaJ mice were purchased  from  The 
Jackson Laboratory (Bar Harbor, ME) and used between 8 and 12 
wk of age. 
Tolerization and Immunization.  HGG was purified from Cohn 
Fraction II of human plasma (lot RC104; Hybrid Laboratories, Glen- 
dale, CA, obtained through the courtesy of the American Red Cross 
National  Fractionation  Center,  Bethesda, MD) by ion exchange 
chromatography  (DEAE  cellulose) as previously described (13). 
DHGG was prepared by ultracentrifugation  of the  HGG in  a 
swinging bucket rotor (SW 50.1; Beckman Instruments, Inc., Palo 
Alto, CA) at 150,000g for 150 rain. After centrifugation, the upper 
quarter of the solution was carefully removed and diluted to the 
appropriate concentration  with 0.15 M pyrogen-ffee NaC1. To in- 
duce tolerance, 2.5 mg DHGG was injected intraperitoneaUy. Mice 
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of 200/zg HGG emulsified in CFA. Mice challenged with KLH 
(Calbiochem, San Diego, CA) were similarly injected with a total 
of 100/~g  KLH in CFA. 
Cell Preparations.  Inguinal and popliteal lymph nodes were asep- 
tically removed from mice and dissociated into single-cell suspen- 
sions. Cells (pooled from four mice per group unless otherwise 
indicated) were then incubated with mAbs to B220 (RA3-6B2, 
rat IgG2a), CD8c~ (53-6.7, rat IgG2a), CDfB (53-5.8, rat IgGl), 
IA  k (11-5.2, mouse  IgG2b),  and  the  TCIL-y/5 (GL3,  hamster 
IgG) (all mAbs from PharMingen, San Diego, CA) as well as mAbs 
to Mac-lc, and the heat-stable antigen. Hybridoma cells producing 
antibody to Mac-lc~ (M1/70, rat IgG2b) were obtained from the 
American Type Culture Collection (Rockviile, MD) and the IgG2b 
fraction was generously provided by Dr. D. N. Ernst (The Scripps 
Research Institute). Hybridoma cells secreting antibody to the heat- 
stable antigen (Jlld.2, IgM) were a generous gift of  Dr. S. R. Webb 
(The Scripps Research Institute),  and the antibody was used as a 
hybridoma  supematant.  CD4+-enriched  cells were  negatively 
selected using magnetic beads coated with goat anti-rat IgG and 
goat anti-mouse IgM (Advanced  Magnetics, Inc., Cambridge, MA). 
Splenic cells depleted of T cells were used as APC. 
Proliferation Assay.  CD4 §  lymphocytes were cultured 
at 37~  in 5% COs in RPMI-1640 media supplemented with 1% 
Nutridoma-SP (Boehringer Mannheim, Indianapolis, IN), 2% fetal 
bovine sera, 2 mM glutamine, 5  x  10  -s M 2-ME, vitamins, so- 
dium pyruvate, 1 mM Hepes, 100 U  penicillin/ml,  and 100/zg 
streptomycin/ml.  2  x  10  s CD4+-enriched  cells were incubated 
with 3  x  10  s APC, with or without HGG at a final concentra- 
tion of 2 mg/ml, in a final volume of 0.2 ml in 96-well flat-bottom 
tissue  culture  plates. Stimulation  with  plate-bound  hamster 
anti-mouse CD3E (145-2C11, PharMingen) was done as previously 
described (14). APC consisted of spleen cells from naive mice that 
were treated twice with anti-Thy 1.2 mAb (New England Nuclear, 
Boston, MA) and rabbit complement (Rabbit Low-Tox  M; Accurate 
Chemical and Scientific  Corp., Westbury, NY) and then passaged 
over Ficoll-Hypaque and irradiated 3,000 tad. Quadruplicate cul- 
tures  were  pulsed  with  1  /~Ci [3H]TdR  (Amersham  Corp., 
Arlington  Heights,  IL)  before  harvest.  The  incorporation  of 
[3H]TdR was measured by standard liquid scintillation counting. 
Lymphokine  Analysis.  CD4+-enriched  cells were cultured  as 
above for proliferation assays, except that 4  x  10  s CD4+-enriched 
cells were incubated with 6  x  105 APC in a final volume of 0.2 
ml. Supernatants were harvested at 48 h and assayed for IL-2  levels 
by a two-site sandwich ELISA essentially as previously described 
(14), using JES6-1A12 anti-mlb2 as a coating antibody and biotin- 
JES6-5H4 anti-mlL-2 as detecting antibody (PharMingen). Wells 
were then incubated with ExtrAvidin alkaline phosphatase before 
addingiv-nitrophenylphosphate substrate (Sigma Chemical Co., St. 
Louis, MO). Absorbance  was measured at 410 nm using a microplate 
reader (model MR600; Dynatech Labs., Inc., ChantiUy, VA). The 
picograms per milliliter oflb2 in supernatants was calculated from 
a log-log plot of absorbance versus concentration  of a standard 
preparation of mlL-2 (PharMingen) with the lower limit of sensi- 
tivity at 10 pg/ml. For quantitation of IL-4, supernatants were har- 
vested at 72 h and assayed  using a murine IL4 ELISA with protein 
G-purified anti-raiL-4 (11Bll, generously provided by Dr. D. N. 
Ernst) used as a coating antibody and biotin-BVD6-24G2 anti-mlIA 
(PharMingen) as detecting antibody. The lower limit of sensitivity 
was 20 pg/ml, using a standard preparation of mlL-4 (PharMingen). 
In some experiments, a murine Ib4 ELISA with a sensitivity of 
5 pg/ml was used (Endogen,  Inc., Boston,  MA). 
Antibody Assays.  Mice were bled 9 d after immunization with 
HGG/CFA and the serum anti-HGG antibody of individual mice 
was assayed by ELISA as previously described (5) with an alkaline 
phosphatase-conjugated sheep anti-mouse IgG (Cappel Laborato- 
ries, Cochranville, PA) with no cross-reaction to HGG as a de- 
veloping antibody and p-nitrophenylphosphate  (Sigma Chemical 
Co.) as substrate. Standard curves were generated using affinity- 
purified polyclonal mouse  anti-human  IgG (Jackson Immuno- 
Research Laboratories, Inc., Avondale, PA). ELISA results are ex- 
pressed as mean units anti-HGG/ml, with 1 unit equivalent to 1 
/~g of standard. To determine the relative contribution of IgG1 and 
IgG2a antibodies to the anti-HGG response, goat anti-mouse IgG1 
and goat anti-mouse IgG2a (Southern Biotechnology Associates, 
Inc., Birmingham, AL) were used as developing antibodies with 
results expressed  as the redprocal of  the dilution at a designated OD. 
Flow Cytofluorometric Analysis.  CD4+-enriched  lymph node 
cells (30  x  10~/ml) were  incubated  with  mAb  to  CD45RB 
(C363.16A, rat IgG2a, PharMingen)  at a concentration  of 0.34 
/~g/ml for I h at 4~  washed, and then incubated with Fbmouse 
anti-rat IgG2a (Serotec Ltd., Oxford, UK) for 30 min at 4~ 
An aliquot of ceils was similarly stained with PE-rat anti-mouse 
CD4 (YTS 191.1, rat IgG2b, Caltag Laboratories, South San Fran- 
cisco, CA) to determine cell purity. Cells were sorted for CD45RB 
using a FACStar  ~ flow cytometer (Becton Dickinson & Co., Moun- 
tain View, CA) and then cultured in triplicate in 96-well half-area 
plates in a final volume of 0.1 ml, with half the number ofT cells 
and APC as in the standard proliferation assay. 
Results 
Total Absence of HGG-specific Proliferation in CIM + T  Cells 
from Tolerant Mice.  The antigen-specific proliferative response 
of CD4 + T  cells  from HGG-primed mice was  assayed in 
mice injected with 200/zg HGG in CFA subcutaneously in 
the hind footpad (control animals) and in mice injected with 
2.5 mg DHGG 15 d before injection with HGG/CFA (tolerant 
animals).  A kinetic analysis of the HGG-specific proliferative 
response of lymph node CD4+-enriched T  cells from con- 
trol and tolerant mice demonstrated that no detectable HGG- 
specific  proliferation could be  observed in  HGG-tolerant 
CD4 + T  cells at any time point throughout a 5-d culture 
period (Fig.  1).  The response of CD4 + T  calls from con- 
trol mice has been shown in other experiments to reach a 
peak at either 96 or 120 h after culture initiation (data not 
shown). 
Tolerance  Induction  in  Both  CD45RB ~i  and  CD45RB l~ 
Subsets of CIM + T  Cells.  Because the CD45 marker defines 
two CD4 + subsets with Thl- and Th2-1ike properties, and 
HGG-specific T calls are found in each subset upon immuni- 
zation (15), the effect of HGG tolerization on the prolifera- 
tive response of each  subset  was  evaluated.  Lymph node 
CD4 +-enriched cells from control and tolerant mice were 
similarly heterogeneous (bimodal) after staining with 16A 
mAb (anti-CD45RB)  (Fig.  2, A  and B). Cells other than 
lymphocytes were excluded by gating based on forward and 
side  scatter.  The  CD4+-enriched  cells  (95%  CD4 +,  as 
indicated by staining with PE-rat anti-mouse CD4) were 
sorted for nonoverlapping subpopulations of CD45RB  ~ and 
CD45RB  l~ cells. Fig.  2 (C and D) shows a reanalysis  of the 
sorted subpopulations in a representative experiment in which 
the  CD45RB hi  calls  comprised  37%  of the  control  and 
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Figure  1.  HGG-specific  proliferative  response  in  CD4+-enriched 
lymph node cells from control and tolerant mice. CD4 §  T cells 
were harvested from lymph nodes of mice injected with HGG in CFA 
9 d previously (control) or in similarly injected mice that had received 2.5 
mg DHGG i.p. 15 d before immunization (tolerant).  Cultures were har- 
vested at the times indicated after a 6-h pulse with 1 #Ci [3H]TdR. 
tolerant  CD4+-enriched  T  cells,  whereas  the CD45RB l~ 
cells were 16 and  14%  of the sorted control and tolerant 
cells, respectively. The antigen-specific proliferative response 
of both of the subpopulations as  well as  the total  gated 
population was assayed. Whereas both control CD45RB hi 
and CD45RB ~~ cells proliferated in response to HGG, nei- 
ther CD45RB hi cells, CD45RB  l~ cells, nor the total gated 
CD4 +-enriched cells from tolerant animals responded above 
background when stimulated with HGG (Fig. 3). Tolerant 
CD4+-enriched  cells  and  the  CD45RB hi and  CD45RB l~ 
subpopulations responded as well as control cells to stimula- 
tion with plate-bound anti-CD3  (data  not shown)￿9 
Decreased Antigen-specific Induction of lL-2 and 11.,-4 Secre- 
tion in CD4 +-enriched T  Cells from  Tolerant Mice.  Because 
IL-2 and IL-4 secretion are functions of Thl- and Th2-1ike 
cells, respectively, the effect of tolerization on these functions 
was also evaluated. In preliminary experiments, IL-2 could 
readily  be detected in  supernatants  of antigen-stimulated 
CD4 +-enriched cells from lymph nodes of mice immunized 
with HGG in CFA, whereas IL-4 production was barely de- 
tectable or absent. Because substantial IL-4 production has 
been  reported  after  antigen  stimulation of KLH-primed 
CD4 +  lymph node cells  (16), we assayed IL-2  and IL-4 
production in CD4 +-enriched lymph node cells from HGG/ 
CFA-immunized mice and  similarly  injected KLH/CFA- 
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Figure 2.  Expression of CD45RB on CD4 +  -enriched lymph node cells 
from control and tolerant mice. CD4+-enriched T cells were isolated from 
lymph nodes of mice injected with HGG in CFA 11 d previously (control) 
or in similarly injected mice that had received 2.5 mg DHGG i.p. 20 d 
before immunization (tolerant). Cells were stained with FITC-anti-CD45RB 
as described in Materials and Methods. Results are expressed as frequency 
distributions of CD45RB expression on gated cells (A) control cells; (B) 
tolerant  cells. Cells  were  sorted  for  nonoverlapping  populations  of 
CD45RB  hi and CD45RB  l~ cells. A composite of the reanalysis of sorted 
CD45RB  hi and CD45RB  i~  cells is shown for control (C) and tolerant (D) 
cells. 
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Figure 3.  HGG-specific proliferation  of CD45RB  hl and CD45RB  1o 
subsets of CD4 + lymph node cells from control and tolerant mice. Ag- 
specific proliferative responses (net cpm) of CD45RB  hi and CD45RBIo 
subpopulations of CD4 +-enriched T cells from control and tolerant mice 
are as described in Fig. 2. Cultures were harvested at 100 h after a 12-h 
pulse with [3HITdR.. Numbers in parentheses indicate day 9 serum anti- 
body levels (ELISA U/ml). 
1639  Romball and Weigle Table  1.  Comparison of the Antigen-specific Proliferative and IL-4 Responses of CD4+-enriched Cells from  Lymph Nodes 
of HGG- and KLH-primed Mice 
Proliferation  response 
[3H]TdR uptake (cpm) 
Culture additions  HGG CD4 §  KLH CD4 §  HGG CD4 § 
IL-4 production 
KLH  CD4+ 
pg/ml 
CD4 + +APC  3,487  +_  1,133  3,987  +  543  <20  <20 
CD4 + +APC+Ag  32,510  +  6,933  212,551  +_ 8,674  <20  213  +  6 
CD4++APC+oeCD3  103,458  +  3,122  147,090  +  15,331  <20  57  _+  1 
CD4+-ertriched  T cells were harvested from lymph nodes of mice primed 5 d previously with either HGG/CFA or KLH/CFA. Proliferative responses 
were assayed at  115  h,  after  a 24-h  pulse  with [3H]TdR..  IL-4  was  assayed in supernatant  from cells cultured for 70 h. 
immunized mice￿9 Using identical conditions for in vitro stim- 
ulation  and lymphokine  assay,  CD4 +-enriched  cells  from 
KLH-primed cells were shown to produce substantial  amounts 
of IL-4  after  KLH  stimulation  in  vitro,  whereas  CD4 +- 
enriched  T  cells  from  HGG-primed  mice were markedly 
deficient in their ability to produce this lymphokine in re- 
sponse to antigen stimulation (Table 1). Fig. 4 details the re- 
sponse of control and tolerant cells in an experiment where 
low but significant levels of IL-4 were generated from con- 
trol cells after in vitro stimulation with antigen￿9 As shown 
previously, control CD4 +-enriched lymph node cells proli- 
ferated to both antigen and plate-bound anti-CD3.  In con- 
trast, a total lack of antigen-specific  proliferation was observed 
in CD4 +-enriched cells from tolerant mice. However, these 
cells were capable of proliferating to plate-bound anti-CD3 
(Fig.  4 A).  Compared with control mice,  serum antibody 
levels were reduced by 98% in tolerant mice (Fig. 4 B). Fur- 
thermore,  a marked suppression of IL-2 levels was observed 
in  supernatants  of  antigen-stimulated  tolerant  CD4 +- 
enriched cells compared with control levels  (Fig.  4  C).  In 
contrast  to the low but significant  levels of IL-4 produced 
by CD4 +-enriched cells from control mice, Ib4 levels from 
antigen-stimulated tolerant mice were reduced to below the 
limits of detection, as assessed by an assay sensitive to 5 pg/ml 
(Fig. 4 D). Plate-bound anti-CD3 induced high levels of IL- 
2 and IL-4 production in both control and tolerant CD4 +- 
enriched cells￿9 
Anti-HGG  Antibody Production by Individual  Control and 
Tolerant Mice and Its Relative Isotype Distribution.  In occasional 
experiments, significant anti-HGG antibody can be detected 
in serum from a few of the tolerant mice after immunization 
with HGG in CFA. Thus,  in these mice, at least some of 
both B and T cells must escape tolerance induction and, under 
stringent conditions of immunization, be capable of mounting 
an antibody response. Because IFN-y has been shown to stimu- 
late the production of antibody of the IgG2a isotype, whereas 
IL-4 enhances the production of antibody of the IgG1 iso- 
type (17,  18),  the relative contribution of these isotypes to 
the anti-HGG antibody response was analyzed by determining 
the reciprocal dilution of serum giving a selected OD reading 
at 410 nm after addition of alkaline  phosphatase-conjugated 
IgG, IgG1, or IgG2a to HGG-coated plates incubated with 
dilutions of serum samples. The total anti-HGG response of 
control mice assayed in this manner averaged 20,625, whereas 
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Figure 4.  HGG-specific proliferative response, serum antibody, and lym- 
phokine response from control and tolerant mice. CD4 +-enriched T cells 
were harvested  from lymph nodes of mice injected with HGG in CFA 
11 d previously (control)  or in similarly injected mice that had received 2.5 
mg DHGG i.p. 25 d before immunization. Proliferative responses are net 
cpm of CD4 + cells incubated  with APC and either HGG or anti-CD3. 
Cultures were harvested at 120 h after an 8-h pulse with [3HITdR (A). 
Lymphokines were assayed in supernatants  of cultures  harvested at 48 h 
for Ib2 (B) or 72 h for Ib4 (D). Antibody was measured in serum from 
mice bled 9 d after immunization (/3). 
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CBA/CaJ Mice Immunized with HGG-CFA 
Percent reduction from control response 
Tolerant 
mouse no.  IgG  IgG2a  IgG1 
1  85  99  73 
2  69  100  57 
3  99  100  100 
4  98  100  99 
5  85  87  87 
6  100  100  100 
7  87  99  88 
8  96  100  98 
Units anti-HGG/ml  +  SD 
Control 
average 
(n  =  8)  20,625  _+  4,517  6,575  +  3,632  4,668 +  1,606 
Normal mice (control animals) or mice pretreated  10 d previously with 
DHGG  (tolerant  animals)  were  bled  9  d  after  immunization with 
HGG/CFA. Serial dilutions of serum were  incubated on HGG-coated 
plates followed by alkaline-phosphatase conjugates of either anti-mouse 
IgG, anti-mouse IgG2a, or anti-mouse IgG1. Units of anti-HGG were 
determined as the reciprocal dilution of serum at a constant OD in the 
linear range. 
the response of tolerant mice was 2,097. Although the total 
IgG anti-HGG response of eight tolerant mice showed a sup- 
pression from the average control response ranging from 60 
to 100%, the suppression of the IgG2a anti-HGG response 
ranged from 87 to 100% (Table 2). On the other hand, sup- 
pression of the IgG1 anti-HGG response ranged from 57 to 
100% of control responses. In several of these mice (nos. 1, 
2,  5),  although the IgG2a anti-HGG response was totally 
suppressed (99-100%),  significant levels of IgG1 antibody 
to HGG were still  produced. All three of these mice also 
showed a leaky tolerance at the IgG anti-HGG level. These 
results suggest that tolerance can be induced in both Thl- 
and Th2-1ike T cell subpopulations, although if tolerance is 
not complete, responsiveness is most readily observed in the 
Th2-1ike subpopulation. 
Discussion 
A solid tolerant state was induced in CD4 § T  cells after 
a single injection of DHGG in CBA/CaJ mice. This tolerant 
state was manifested by inhibition oft cell proliferation, lym- 
phokine secretion, and antibody helper activity. In contrast 
to untreated immunized mice, CD4 + cells from tolerized, 
immunized mice failed to proliferate upon in vitro stimula- 
tion with HGG, and tolerant mice showed a marked inhibi- 
tion of serum anti-HGG antibody.  Furthermore, antigen- 
specific proliferation was abrogated in both the CD45RB hi 
and CD45RB I~ T  cell subpopulations from tolerant mice. 
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IL-2  production  was  dramatically  decreased  in  antigen- 
stimulated CD4 + cells from tolerant mice compared with 
control CD4 + cells. Ahhough HGG stimulation of control 
CD4 § cells did not consistently induce significant levels of 
IL-4, in experiments where IL-4 levels could be quantitated, 
IL-4 levels in supernatants from antigen-stimulated tolerant 
CD4 + cells were reduced. 
These observations are in contrast to those of De Wit et 
al.  (12),  who reported that T  cells from tolerized but not 
control mice immunized with HGG/CFA produce high levels 
of IL-4 but reduced levels of IL-2. These workers interpreted 
their data to mean that tolerance is induced in Thl-like calls, 
whereas Th2-1ike cells are activated and expanded. The differ- 
ence in the latter observations from our data could be ex- 
plained by impurities in their HGG preparation, differences 
in specifidties of the assays used, or, most likely,  by differ- 
ences in the level of tolerance induced. Previous studies have 
shown that the presence of LPS or aggregates of HGG (as 
well as other inducers of IL-1 production) can interfere with 
the induction of tolerance to DHGG, resulting in priming 
to HGG (4). The significant amount of HGG-induced prolifer- 
ative response in T  cells from "tolerant" mice observed by 
De Wit et al. (12) at 72 h, and 24-48 h before the peak re- 
sponse (see Fig. 1), suggests that total T cell tolerance may 
not have been induced in their study. In our study, in a11 
experiments to date (five), no IL-4 could be detected in antigen- 
stimulated CD4 + cells from HGG-tolerant mice. Our failure 
to  detect HGG-stimulated  IL-4 production in  CD4+-en - 
riched T cells from tolerant mice is not likely to be due to 
the lack of sensitivity of the IL-4 ELISA assay used (5 pg/ml) 
because low but significant levels of IL-4 could be detected 
in CD4 +-enriched cells from control mice stimulated with 
HGG in some experiments. Furthermore, this assay readily 
detected IL-4 secretion in CD4 + cells  from KLH-immu- 
nized mice stimulated in vitro with KLH. 
The finding of enhanced T helper activity in tolerized, im- 
munized mice by De Wit et al. is incompatible with estab- 
lished features of the HGG mouse model and with the in 
vitro data obtained with Th clones. Tolerance at the T  cell 
hdper compartment after injection of DHGG was previously 
shown by cell transfer techniques (2,  19) and by the failure 
to stimulate T  cell helper activity in mice long after toler- 
ance in the B cell compartment was lost (20). Using a similar 
model,  Eynon and  Parker (21)  also  demonstrated a  solid 
tolerant state in T helper function. In these studies, tolerance 
was induced with ultracentrifuged Fab fragments of rabbit 
anti-mouse IgD. The tolerant state of T cell helper function 
in the latter study was readily demonstrated after transfer of 
the T  cells  to SCID  mice.  Furthermore, although HGG- 
specific T cell proliferation is not inhibited in Th2 clones ex- 
posed to tolerogen, T helper activity is readily tolerized (10). 
The ability of De Wit et al. (12) to generate anti-TNP anti- 
body by injecting tolerant mice with hapten-conjugated HGG 
is not surprising because the ability of hapten-conjugated pro- 
teins to bypass tolerant T cells and activate competent B calls 
in vivo is well established (for reviews see references 1 and 
22). The ability to inhibit the proliferation of IL-4-producing 
Th2-1ike cells in the present in vivo studies, in light of the inability to inhibit the proliferation (but not help) in HGG- 
specific Th2 clones, suggests that, in the former, tolerance 
is induced in precursors of Th2-1ike cells rather than the Th2 
cells themselves. 
The ability of tolerance to suppress  functions of subsets 
of CD4 + cells further supports  the contention that toler- 
ance can be induced in two subsets that have, at least, some 
of the characteristics of Thl and Th2 cell clones. The CD45 
(leukocyte common antigen) surface marker has been shown 
to be differentially expressed on CD4*  cells (23, 24).  The 
extracellular domain of the CD45 molecule is encoded by 
three exons in mice (A, B, and C) and expression of various 
isoforms of this molecule is achieved by differential splicing 
of precursor mRNA (25).  Lymphocytes that express  high 
levels of CD45R.8  (CD45RB hi) have been demonstrated to 
secrete IL-2 upon mitogen stimulation and were thought to be 
naive cells, whereas CD45RB z~ cells secrete predominantly 
IL-4 (26) and have been associated  with activated memory 
lymphocytes. However, both CD45RB hi and CD45RB l~ T 
cells from  HGG/CFA  injected mice have been shown to 
proliferate to antigen in vitro (15), as has also recently been 
shown with other antigens (for a review see reference 27), 
suggesting that neither antigen-specific subset is naive. Fur- 
thermore, when HGG-primed cells are separated on the basis 
of the memory marker CD44,  all the cells proliferating to 
antigen belong to the memory (CD44  ~) subset.  Our finding 
that, as indicated by proliferation, a solid tolerant state is in- 
duced  in  both  CD45RB ~i  and  CD45RB 1~ subsets  after 
tolerogen and subsequent immunization (Fig. 3) corroborates 
our data on the lack of both IL-2 and IL-4 lymphokine produc- 
tion by tolerized CD4 + cells. Similar preliminary observa- 
tions have been reported by us with CD45RB  cell subsets 
from control and tolerant C57BL/6  mice (28~. 
Although a solid state of tolerance can be induced after 
the in vivo injection of DHGG, our data regarding the sub- 
class of anti-HGG antibody produced by control and tolerant 
mice  and  data  by  others  (12, 29)  suggest  that  the  IL- 
2-producing Thl-like cells are more susceptible to the in- 
duction of tolerance than are the IL-4-producing Th2-1ike 
cells. The failure to always completely inhibit antibody produc- 
tion in every mouse by pretreatment with DHGG suggests 
that tolerance is not always absolute in the HGG mouse model. 
The findings that when tolerance is not always complete as 
far as total antibody is concerned and that  this leakage is 
reflected in the IgG1 anti-HGG response suggest that when 
tolerance is incomplete, the leakage is most likely at the IL- 
4-producing cells. IgG1 antibody has been associated  with 
Th2-1ike  II~4-producing cells, whereas IgG2a has been as- 
sociated with Thl-like IL-2-producing cells (17).  Such in- 
complete tolerance may explain the recent findings of Bur- 
stein et al. (29),  who reported that injection of TNP-OVA 
and TNP-KLH into mice induced tolerance in IL-2- but not 
IL-4-producing cells. It is unlikely that a solid tolerant state 
is induced with OVA conjugates because OVA, with a mo- 
lecular weight of 39,000, is rapidly cleared from the circula- 
tion through the glomerular capillaries before it can adequately 
diffuse into the extravascular spaces (30-32) and is thus, at 
least in the rabbit,  a poor tolerogen (30).  Likewise, KLH, 
a large molecule that is rapidly removed from the circula- 
tion, does not equilibrate between the intra- and extravas- 
cular spaces and requires extremely high and repeated doses 
to significantly suppress  antibody responses in rabbits (33). 
Furthermore, the response to KLH may be unique in that 
it appears  to cross-react with mycobacterial antigens (34). 
Thus, the inability of TNP-OVA and TNP-KLH to induce 
tolerance in IL-4-producing Th2-1ike calls is most likely the 
result of the combination of a poor tolerogenic signal with 
the relative resistance of IL-4-producing (Th2-Iike) ceils to 
be tolerized compared with IL-2-producing (Thl-like) cells. 
HGG, on the other hand, equilibrates between the intra- and 
extravascular fluid spaces at a ratio (50:50) predicted by a func- 
tion of its diffusion coefficient (35) and persists  in the body 
fluids of mice with a half-life of 7 d (36). Recently, Peterson 
et al. (37) have also suggested that IL-4-producing Th2-1ike 
cells  are  more  resistant  to  tolerance  induction  than  IL- 
2-producing Thl-like cells. They reported that injection of 
mice with inactivated Theiler's routine encephalomyelitis virus 
resulted in suppression of IL-2 secretion and IgG2a antibody 
production, but not of IL-4 secretion or IgG1 antibody produc- 
tion. Again, this particulate antigen would be rapidly cleared 
from circulation upon injection (for a review see reference 
38);  thus, it is not surprising that tolerance occurs only in 
the IL-2-producing cells. It is likely that the use of antigens 
or protocols that in the past have failed to show tolerance 
induction based on total T  cell proliferation or total anti- 
body production will now be shown to induce such "split" 
tolerance in CD4 + subsets using lymphokine secretion as 
the assay. Such loss of self-tolerance at the IL-4-producing 
Th2-1ike cell level may be instrumental in antibody-mediated 
autoimmunity. The observed differences in the susceptibility 
of Thl- and Th2-1ike cells to tolerance induction is not sur- 
prising because antigen-specific Thl and Th2 cells differ dra- 
matically in lymphokine requirements (39), lymphokine secre- 
tion (39),  early activation events (40),  use of APC (39, 40), 
and pathway of tolerance induction (10,  41,  42). 
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